• Phase

    Alumni community member

  • Contact person

    Helene Hartman, CEO

  • Email


  • Area

    Pharma & Biotech


The research of Xinnate´s co-founder at Lund University has resulted in proprietary platform technology within advanced wound care, which consists of specific peptides appearing in nature’s host defense. The company has developed a lead candidate that is currently in clinical trials for inflammatory skin diseases.

Did you know?

The body’s natural defence to promote healing is the secret in Xinnate´s gel.

© 2023 Copyright SmiLe Incubator